Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ALDR

Alder Biopharmaceuticals (ALDR) Stock Price, News & Analysis

Alder Biopharmaceuticals logo

About Alder Biopharmaceuticals Stock (NASDAQ:ALDR)

Advanced Chart

Key Stats

Today's Range
$18.88
$18.88
50-Day Range
$18.88
$18.88
52-Week Range
$8.39
$19.12
Volume
N/A
Average Volume
5.12 million shs
Market Capitalization
$1.58 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ALDR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alder Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ALDR Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
Alder Hey hospital warning after measles spike
See More Headlines

ALDR Stock Analysis - Frequently Asked Questions

Alder Biopharmaceuticals Inc (NASDAQ:ALDR) issued its quarterly earnings results on Tuesday, August, 7th. The biopharmaceutical company reported ($1.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.05) by $0.01.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alder Biopharmaceuticals investors own include Bristol Myers Squibb (BMY), (CPXX) (CPXX), NVIDIA (NVDA), Celldex Therapeutics (CLDX), Meta Platforms (META), Gilead Sciences (GILD) and Micron Technology (MU).

Company Calendar

Last Earnings
8/07/2018
Today
7/10/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ALDR
CIK
1423824
Fax
N/A
Employees
202
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$296.43 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.62 million
Price / Cash Flow
N/A
Book Value
$1.61 per share
Price / Book
11.73

Miscellaneous

Free Float
N/A
Market Cap
$1.58 billion
Optionable
Optionable
Beta
2.64
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:ALDR) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners